Literature DB >> 27802898

Oxymatrine attenuated isoproterenol-induced heart failure in rats via regulation of COX-2/PGI2 pathway.

Ru Zhou1, Qingbin Xu2, Yehua Xu2, Aiqin Xiong2, Yang Wang2, Ping Ma3.   

Abstract

Oxymatrine (OMT) is an active constituent of traditional Chinese herb Sophora japonica Ait which has been shown to exert potent anti-inflammatory,anti-oxidant and anti-fibrosis properties. Our previous studies have demonstrated that OMT has protective effects on isoproterenol-induced heart failure in rats through regulation of DDAH/ADMA metabolism pathway.In this study,we further investigated whether OMT could attenuate isoproterenol-induced heart failure through the regulation of COX-2/PGI2 pathway. Heart failure was induced in Sprague-Dawley rats by 5mg/kg isoproterenol subcutaneous injection for 7days. The rats were maintained on normal diet and randomly divided into five groups: control, isoproterenol, isoproterenol with OMT (50, 100mg/kg), and OMT alone groups (n=12 in each group). Serum brain natruretic peptide (BNP, a heart failure biomarker), histopathological variables, expression of Cytosolic phospholipase A2 (cPLA2), cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2) and Prostacyclin synthase (PGIS) were analysed. Administration of OMT significantly reduced the increased BNP in plasm of isoproterenol-induced rats, attenuated cardiac fibrosis,suppressed overexpression of myocardial COX-1 expression, up-regulated COX-2 and PGIS expression, but had no effects on isoproterenol-induced elevated protein cPLA2. And compared with control group, any indexes in sham rats treated with OMT (100mg/kg) alone were unaltered. These results demonstrated that OMT has cardioprotective effects on isoproterenol-induced heart failure in rats by regulating COX-2/PGI2 pathway.
Copyright © 2016. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Cyclooxygenase-1; Cyclooxygenase-2; Cytosolic phospholipase A(2); Heart failue; Isoproterenol; Oxymatrine; Prostacyclin synthase

Mesh:

Substances:

Year:  2016        PMID: 27802898     DOI: 10.1016/j.biopha.2016.10.070

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Protective effect of Oxymatrine against acute spinal cord injury in rats via modulating oxidative stress, inflammation and apoptosis.

Authors:  Binggang Guan; Rongchun Chen; Mingliang Zhong; Ning Liu; Qin Chen
Journal:  Metab Brain Dis       Date:  2019-12-15       Impact factor: 3.584

Review 2.  Genus Sophora: a comprehensive review on secondary chemical metabolites and their biological aspects from past achievements to future perspectives.

Authors:  Howaida I Abd-Alla; Dalila Souguir; Mohamed O Radwan
Journal:  Arch Pharm Res       Date:  2021-12-15       Impact factor: 4.946

3.  Oxymatrine Alleviates Hyperglycemic Cerebral Ischemia/Reperfusion Injury via Protecting Microvessel.

Authors:  Wen-Jun Wang; Yan-Mei Ma; Mao-Tao He; Deng-Hai Zhang; Rui Wang; Li Jing; Jian-Zhong Zhang
Journal:  Neurochem Res       Date:  2022-01-31       Impact factor: 3.996

4.  The deleterious role of the prostaglandin E2 EP3 receptor in angiotensin II hypertension.

Authors:  Timothy D Bryson; Teja S Pandrangi; Safa Z Khan; Jiang Xu; Tengis S Pavlov; Pablo A Ortiz; Edward Peterson; Pamela Harding
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-06       Impact factor: 4.733

5.  Oxymatrine Inhibits Influenza A Virus Replication and Inflammation via TLR4, p38 MAPK and NF-κB Pathways.

Authors:  Jian-Ping Dai; Qian-Wen Wang; Yun Su; Li-Ming Gu; Hui-Xiong Deng; Xiao-Xuan Chen; Wei-Zhong Li; Kang-Sheng Li
Journal:  Int J Mol Sci       Date:  2018-03-23       Impact factor: 5.923

6.  Oxymatrine Inhibits Transforming Growth Factor β1 (TGF-β1)-Induced Cardiac Fibroblast-to-Myofibroblast Transformation (FMT) by Mediating the Notch Signaling Pathway In Vitro.

Authors:  Linglu Zhao; Yini Xu; Ling Tao; Yu Yang; Xiangchun Shen; Ling Li; Peng Luo
Journal:  Med Sci Monit       Date:  2018-09-09

7.  Fuziline alleviates isoproterenol-induced myocardial injury by inhibiting ROS-triggered endoplasmic reticulum stress via PERK/eIF2α/ATF4/Chop pathway.

Authors:  Cai-Lian Fan; Zhi-Hong Yao; Meng-Nan Ye; Lei-Lei Fu; Guo-Nian Zhu; Yi Dai; Xin-Sheng Yao
Journal:  J Cell Mol Med       Date:  2019-12-07       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.